Literature DB >> 2298839

Continuous nimodipine treatment attenuates cortical infarction in rats subjected to 24 hours of focal cerebral ischemia.

M Jacewicz1, S Brint, J Tanabe, W A Pulsinelli.   

Abstract

Focal cerebral infarction and edema were measured in rats (Wistar, Fisher 344, and spontaneously hypertensive strains) pretreated with nimodipine (2 micrograms/kg/min i.v.) or its vehicle and subjected to the tandem occlusion of the middle cerebral and common carotid arteries. Animals awoke from anesthesia 10-15 min after onset of ischemia and continued to receive treatment over a 24-h survival period. Cortical infarction and edema were quantified by image analysis of frozen brain sections processed for histology. Nimodipine-treated rats developed 20-60% smaller cortical infarct volumes than controls (p less than 0.002). Cortical edema was reduced proportionately to the decrease in infarct volume and constituted approximately 36% of the infarct volume. Nimodipine caused a mild hypotensive response that did not aggravate ischemic brain damage. The results indicate that continuous nimodipine treatment, started before induction of focal cerebral ischemia, can attenuate ischemic brain damage and edema as late as 24 h after the onset of ischemia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2298839     DOI: 10.1038/jcbfm.1990.11

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  6 in total

1.  The neuroprotective effect of a nitric oxide inhibitor in a rat model of focal cerebral ischaemia.

Authors:  A Buisson; M Plotkine; R G Boulu
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

2.  Progression from ischemic injury to infarct following middle cerebral artery occlusion in the rat.

Authors:  J H Garcia; Y Yoshida; H Chen; Y Li; Z G Zhang; J Lian; S Chen; M Chopp
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

3.  Pretreatment with a competitive NMDA antagonist D-CPPene attenuates focal cerebral infarction and brain swelling in awake rats.

Authors:  C K Park; J McCulloch; J K Kang; C R Choi
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

4.  A trial of the effect of nimodipine on outcome after head injury.

Authors:  I Bailey; A Bell; J Gray; R Gullan; O Heiskanan; P V Marks; H Marsh; D A Mendelow; G Murray; J Ohman
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

Review 5.  Nimodipine. A review of its pharmacological properties, and therapeutic efficacy in cerebral disorders.

Authors:  A N Wadworth; D McTavish
Journal:  Drugs Aging       Date:  1992 Jul-Aug       Impact factor: 3.923

6.  Hypoglycaemic brain damage: effect of a dihydropyridine calcium channel antagonist in rats.

Authors:  R N Auer; L G Anderson
Journal:  Diabetologia       Date:  1996-02       Impact factor: 10.122

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.